Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

680
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
680
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.7K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

1.7K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.7K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

574
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
574
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultrasound-guided Reduction of Colle's fracture does not assist in Achieving Better Radiographic Indices - Results of a Randomised Controlled Trial.

Malaysian orthopaedic journal·2024
Same author

Improving the Accuracy of Corrective Osteotomy for Congenital Radio Ulnar Synostosis using the Axis of Rotation of the Forearm as a Guide.

Malaysian orthopaedic journal·2023
Same author

Impact of dust in the decay of blast waves produced by a nuclear explosion.

Proceedings. Mathematical, physical, and engineering sciences·2020
Same author

Emerging Advanced Technologies Developed by IPR for Bio Medical Applications ‑.A Review.

Neurology India·2020
Same author

Neglected Anterior Dislocation of the Elbow Joint: Case Report of a Rare Injury.

Malaysian orthopaedic journal·2018
Same author

DISSEMINATED ASPERGILLOSIS IN AN IMMUNOCOMPETENT HOST WITH PREDISPOSING RISK FACTORS: A Case Report.

Medical journal, Armed Forces India·2017

Related Experiment Video

Updated: Feb 25, 2026

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

1.4K

DRUG RESISTANT TUBERCULOSIS - THE EMERGING SCENARIO.

J Jena1, S K Nema1, B N Panda2

  • 1Classified Specialists Pathology, Military Hospital (CTC), Pune 411 040.

Medical Journal, Armed Forces India
|August 4, 2017
PubMed
Summary

A study found that 13.7% of pulmonary tuberculosis patients exhibited drug resistance, with streptomycin resistance being most common. Acquired multidrug resistance was prevalent in these cases.

Keywords:
Antitubercular agentsDrug resistance microbialTuberculosis

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K

Related Experiment Videos

Last Updated: Feb 25, 2026

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

1.4K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Tuberculosis (TB) remains a significant global health challenge.
  • Drug resistance in Mycobacterium tuberculosis complicates treatment and control efforts.
  • Understanding drug resistance patterns is crucial for effective TB management strategies.

Purpose of the Study:

  • To determine the prevalence of drug resistance in Mycobacterium tuberculosis isolates from pulmonary TB patients.
  • To identify common drug resistance patterns, including single and multidrug resistance.
  • To differentiate between initial and acquired drug resistance in the patient cohort.

Main Methods:

  • Retrospective analysis of 2288 pulmonary tuberculosis patients treated between April 1992 and September 1994.
  • Isolation and identification of Mycobacterium tuberculosis from sputum samples.
  • Indirect drug susceptibility testing using drug-incorporated Lowenstein-Jensen medium.

Main Results:

  • Mycobacterium tuberculosis was isolated from 45.3% of patients.
  • Overall drug resistance was observed in 13.7% of isolates.
  • Streptomycin resistance (8.3%) was most frequent, followed by isoniazid (5.7%) and rifampicin (5.0%).
  • Single drug resistance occurred in 8.3% and resistance to two or more drugs in 5.4% of patients.
  • Initial drug resistance (83 cases) was more common than acquired drug resistance (59 cases).
  • Multidrug resistance was predominantly acquired (71.4% of drug-resistant isolates).

Conclusions:

  • A significant proportion of pulmonary tuberculosis cases exhibited drug resistance during the study period.
  • Streptomycin, isoniazid, and rifampicin resistance are key concerns in this population.
  • The high rate of acquired multidrug resistance highlights the need for improved treatment adherence and monitoring.